Researchers from the Sleep and Performance Research Center at Washington State University (WSU) have partnered with the University of Washington in the US to test a new sleep measurement technology for chronic insomnia.

The three-year project will evaluate the effectiveness of the new S+ non-contact sensor designed to measure timing, quantity and quality of sleep.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

S+ features an in-built sleep coaching functionality called S+ Mentor that uses an app on the connected mobile or tablet to send sleep scores and charts to users.

The function also provides individualised suggestions to improve sleep. The sleep tracking technology has been previously validated in healthy people and those with obstructive sleep apnea.

Study principal investigator Devon Grant said: “We will investigate to what extent this technology can accurately measure insomniacs’ sleep patterns over days and weeks and provide tailored improvements in their sleep.

“This could help expand cost-effective therapy options available to this undertreated population.”

“This could help expand cost-effective therapy options available to this undertreated population.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The two-month monitoring study will enrol 90 adults suffering from chronic insomnia and 30 healthy sleepers in the Spokane and Seattle regions of the country.

One set of participants will be monitored with the new technology, while others will be subjected to sleep monitoring along with participation in an online cognitive behavioural therapy for insomnia (CBT-I) programme or sleep coaching through the technology’s mentoring feature.

The study will analyse S+ technology’s ability to accurately measure sleep and will determine if the efficacy of its coaching functionality for treating chronic insomnia is at least similar to that of the online CBT-I.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact